Steven W Adams

Title: The Innovations of Steven W. Adams

Introduction

Steven W. Adams is a notable inventor based in Sunnyvale, CA (US). He has made significant contributions to the field of biomedical research, particularly in the area of bone formation and regulation. With a total of 3 patents to his name, Adams has focused on developing innovative therapies to address various bone-related disorders.

Latest Patents

Adams' latest patents include groundbreaking inventions such as the IGF/IGFBP complex for promoting bone formation. This invention involves administering IGF and IGFBP to stimulate new bone formation in subjects suffering from bone loss due to various conditions, including bone marrow disorders, connective tissue disorders, and chronic diseases. Another significant patent is the high dose IGF-1 therapy, which presents a method for administering a complex of IGF-I and IGFBP-3 at unexpectedly high doses without inducing IGF-I-related side effects. These innovations have the potential to transform treatment options for patients with bone-related health issues.

Career Highlights

Steven W. Adams is currently associated with Celtrix Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating therapies that can significantly improve the quality of life for individuals with bone disorders.

Collaborations

Adams has collaborated with notable colleagues, including David M. Rosen and Rosa Armstrong. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic solutions.

Conclusion

Steven W. Adams is a distinguished inventor whose work in the field of bone health has led to significant advancements in treatment options. His innovative patents and collaborations reflect his commitment to improving patient outcomes in the biomedical sector.